A detailed history of Zhang Financial LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Zhang Financial LLC holds 3,908 shares of VRTX stock, worth $1.78 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,908
Previous 3,775 3.52%
Holding current value
$1.78 Million
Previous $1.58 Million 16.11%
% of portfolio
0.13%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$392.81 - $485.53 $52,243 - $64,575
133 Added 3.52%
3,908 $1.83 Million
Q1 2024

Apr 24, 2024

BUY
$407.69 - $446.08 $191,614 - $209,657
470 Added 14.22%
3,775 $1.58 Million
Q4 2023

Jan 31, 2024

BUY
$343.0 - $410.68 $315,560 - $377,825
920 Added 38.57%
3,305 $1.34 Million
Q3 2023

Oct 11, 2023

BUY
$338.18 - $362.46 $313,492 - $336,000
927 Added 63.58%
2,385 $829,000
Q2 2023

Jul 18, 2023

BUY
$314.42 - $351.91 $458,424 - $513,084
1,458 New
1,458 $513,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $117B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Zhang Financial LLC Portfolio

Follow Zhang Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zhang Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zhang Financial LLC with notifications on news.